Before you decide you have "covered" infectious diseases and stop doing new questions, verify two things: that you are auditing against the live exam, and that you have evidence of coverage rather than a feeling of it. The first correction matters most — the MRCP(UK) SCE Infectious Diseases was withdrawn, with its final sitting in 2017, so the exam behind this search no longer exists. The live UK infection knowledge exam is the RCPath FRCPath Part 1 in Infection / Combined Infection Certificate Examination (CICE). This is the exam-level checklist that its child articles point back to.
The direct answer, as a checklist rather than a timetable
You can say you have covered the infection blueprint only when you can show, on paper, that:
- Every CICE blueprint domain has a measured first-attempt accuracy on unseen, timed questions — not just "questions attempted".
- Your weak domains are few, named and shrinking across two spaced retests, not merely visited once.
- You have deliberately practised the interpretation formats (Gram films, susceptibility tables, serology panels, imaging, laboratory trends, dosing calculations), not only pure recall.
- Your guidance-sensitive topics are revised against current, dated, UK-jurisdiction sources.
- Your readiness signal comes from unseen, timed, mixed blocks with no topic clustering — not from your overall bank percentage.
If any of those five is missing, you have not finished; you have merely run out of comfortable questions. Everything below turns each line into something you can tick.
Current exam snapshot: what you are actually auditing against
Anchor the audit to the RCPath CICE, not the historical SCE weighting. RCPath describes the CICE as two papers of 100 single best answer questions each (200 total), three hours per paper, computer-delivered, no negative marking, offered twice yearly and standard-set by modified Angoff. It is sat by trainees completing Combined Infection Training (CIT); for infectious diseases and general internal medicine trainees it is the written endpoint, while medical microbiology and virology trainees progress to FRCPath Part 2. Verify current structure and counts on rcpath.org before relying on them. The published content distribution is approximately:
| CICE domain | Approx. official weight |
|---|---|
| Clinical syndromes | 32.5% |
| Antimicrobials | 15% |
| Laboratory practice | 15% |
| Basic science | 10% |
| Public health | 5% |
| Infection prevention and control | 5% |
| Vaccination | 5% |
| HIV | 5% |
| Travel medicine | 5% |
| Health and safety | 2.5% |
The single most useful observation for gap-hunting: clinical syndromes and antimicrobials together are under half the paper, yet they absorb most self-directed revision. Laboratory practice, basic science, and the four 5% domains together make up 45% and are where hidden gaps concentrate.
Build a blueprint coverage table
Completion is not coverage. The way to prove coverage is a table you keep honestly, mapping each official domain to measured evidence. This is the same discipline set out in completion is not coverage; here is the infection-specific template:
| CICE domain (official weight) | Questions attempted (unseen) | First-attempt accuracy | Last reviewed | Confidence (L/M/H) |
|---|---|---|---|---|
| Clinical syndromes (32.5%) | ||||
| Antimicrobials (15%) | ||||
| Laboratory practice (15%) | ||||
| Basic science (10%) | ||||
| Public health (5%) | ||||
| Infection prevention & control (5%) | ||||
| Vaccination (5%) | ||||
| HIV (5%) | ||||
| Travel medicine (5%) | ||||
| Health & safety (2.5%) |
A row with high "attempted" but no recent "last reviewed" date and a low, stale accuracy is a false sense of coverage. A row that is simply empty is an honest gap. Both are more useful than a single headline percentage.
Ten domain-level blind spots most likely to stay hidden
These are the areas self-selected practice tends to skip, because they are uncomfortable, image-heavy or administrative. Have an infection specialist review your own list before you treat it as complete — the point is exam-specific clinician scrutiny, not a generic memory aid.
- Antimicrobial stewardship and OPAT governance — de-escalation, IV-to-oral switch criteria, outpatient parenteral antimicrobial therapy selection and monitoring, allergy de-labelling.
- HIV management detail — PrEP eligibility and monitoring, antiretroviral drug–drug interactions, immune reconstitution inflammatory syndrome, opportunistic-infection prophylaxis thresholds by CD4.
- Imported fever and travel medicine — malaria species, severity criteria and treatment; enteric fever; arboviruses; risk assessment for viral haemorrhagic fever; returning-traveller eosinophilia.
- Tuberculosis, including drug resistance — latent TB and IGRA interpretation, standard and resistant regimens, adverse effects and monitoring, contact tracing.
- Public health and notifiable diseases — statutory notification duties, outbreak roles and definitions, UKHSA involvement, cluster investigation.
- Infection prevention and control — transmission-based precautions, decontamination and sterilisation, healthcare-associated infection surveillance, PPE selection.
- Vaccination in special groups — immunocompromise and asplenia schedules, post-exposure prophylaxis (rabies, hepatitis B, varicella-zoster immunoglobulin), travel and occupational immunisation.
- Laboratory practice — antimicrobial susceptibility testing and EUCAST breakpoints, molecular diagnostics, serology interpretation, blood-culture diagnostics and time-to-positivity.
- Invasive fungal disease — azole interactions and therapeutic drug monitoring, galactomannan and beta-D-glucan interpretation, empirical versus targeted antifungal choice.
- Structured clinical syndromes with rules — infective endocarditis (modified Duke criteria), bone and joint infection, CNS infection and CSF interpretation, sepsis recognition and the immunocompromised host.
Format checklist: prove you have drilled the awkward tasks
Coverage of a topic is not coverage of the task the exam sets on that topic. Confirm deliberate practice in each of these:
- Antimicrobial stewardship: at least one block on de-escalation, switch and duration decisions, not only "which drug treats which bug".
- Outbreak and public health: scenario items on notification, control measures and roles, which recall-heavy revision tends to omit.
- Guideline recency: items whose answer depends on the current guideline, revised against a dated source (see the recency checklist below).
Interpretation checklist
Confirm you have practised, under timed conditions, the interpretation formats the CICE can use: microscopy and Gram films; blood films for malaria; susceptibility tables and MIC interpretation; serology panels for hepatitis B and C, HIV and syphilis; chest and cross-sectional imaging for TB, pneumocystis and abscesses; laboratory trend interpretation (CRP, procalcitonin, CD4 counts, HIV and hepatitis viral loads); and calculations such as renal dose adjustment and therapeutic drug monitoring for gentamicin and vancomycin. If you have never done these against the clock, they are a gap regardless of your topic knowledge.
Recency checklist: date and jurisdiction every guidance-sensitive answer
Some answers move with guidance. For each guidance-sensitive topic, record the source, its date and its jurisdiction, and never assume a revision product is current. UK medicines facts come from the SmPC/eMC, and practice guidance from the bodies below. Topics to date-stamp include:
- HIV PrEP and antiretroviral guidance (BHIVA), sexual-health management (BASHH).
- Sepsis recognition and management (NICE).
- OPAT good-practice recommendations (BSAC / BIA).
- Tuberculosis, including drug-resistant disease (NICE; UKHSA).
- Immunisation and post-exposure prophylaxis (UK immunisation guidance / "Green Book").
- Notifiable diseases and outbreak response (UKHSA).
- Emerging and imported infection alerts (UKHSA), where "current" can mean this quarter.
An answer that was correct against last year's guidance can be wrong today; a dated source column in your notes is what protects you.
Performance checklist: the signals that actually predict readiness
Measure these, not your overall percentage:
- Unseen, timed, mixed accuracy by domain — the only score that reflects the exam.
- Speed — are you inside roughly 1.8 minutes per item without guessing?
- High-confidence error rate — the errors you did not know you were making are the dangerous ones.
- Retention — do spaced retests, ten to fourteen days on, hold up?
- Official-material calibration — how do you perform on RCPath CICE sample questions kept unseen until late?
Stop or continue: a decision tree
Use the measured gap to choose one action per domain, not a global mood.
- Continue new questions where unseen accuracy is below target and still improving.
- Consolidate (stop new questions; retest and space) where unseen accuracy is at target and stable across two spaced retests.
- Simulate (mixed, full-length, timed) where individual domains are strong but you have never assembled them under exam pace.
- Seek teaching where you have a persistent high-confidence error pattern that self-study is not shifting — a reasoning fault, not a fact gap.
- Rest where fatigue is driving careless errors; a tired plateau is not a knowledge gap.
A one-page checklist you can copy
Keep this beside your coverage table and tick weekly:
- I am auditing against the live CICE blueprint, not the withdrawn SCE.
- Every domain has a measured unseen accuracy and a "last reviewed" date.
- Weak domains are named, few and shrinking across two spaced retests.
- I have drilled each interpretation format under the clock.
- Guidance-sensitive topics carry a dated, UK-jurisdiction source.
- My readiness signal is unseen, timed, mixed accuracy — not my bank percentage.
- I have performed on RCPath sample questions kept unseen until late.
- An infection specialist has reviewed my blind-spot list.
Worked example (invented data)
A CIT trainee, six weeks out, fills the coverage table honestly. Clinical syndromes: 420 attempted, 78% first-attempt, high confidence. Antimicrobials: 210 attempted, 72%, medium. Laboratory practice: 60 attempted, 54%, low. Public health: 15 attempted, 47%, low. HIV: 90 attempted, 74%, medium. Travel medicine: 25 attempted, 58%, low. The headline "overall 74%" looked reassuring, but the table exposes three thin, low-accuracy rows (laboratory practice, public health, travel medicine) that together carry 25% of the blueprint. The decision is not "keep grinding clinical syndromes"; it is continue new questions in the three weak domains, simulate to see whether strong domains survive mixed pacing, and stop adding clinical-syndrome volume where accuracy is already stable. That is what the table buys you that a percentage cannot.
Frequently asked questions
How do I know whether I have covered the full SCE Infectious Diseases blueprint? You cannot cover the SCE Infectious Diseases blueprint, because that exam had its final sitting in 2017; you cover the live RCPath CICE blueprint instead. You "know" you have covered it only when your coverage table shows a measured, recent, at-or-above-target unseen accuracy in every domain — with special attention to laboratory practice, public health, infection prevention and control, vaccination and travel medicine, which self-selected practice tends to under-serve. Coverage is a table you can show, not a total you can recall.
Can one question bank be enough for SCE Infectious Diseases? Rarely, and for a structural reason rather than a quality one: once you have reviewed a finite bank's explanations, its questions can no longer measure learning, only memory of the items. A single bank can build breadth, but you need a second, never-reviewed source to supply unseen volume for honest measurement and mixed mocks. For the live CICE, a specialty resource such as the British Infection Association's Learn Infection bank is a strong core, ideally paired with an unseen transfer layer.
What should I measure instead of my overall Q-bank percentage for SCE Infectious Diseases? Measure unseen, timed, mixed accuracy by blueprint domain; your high-confidence error rate; your speed against roughly 1.8 minutes per item; retention on spaced retests; and your performance on official RCPath sample questions kept unseen until late. Your overall bank percentage blends reviewed and unreviewed items and flatters you — it is not your exam score.
When should I stop doing new SCE Infectious Diseases questions? Stop adding new questions in a given domain once unseen, timed accuracy sits at or above your target and holds across two spaced retests roughly two weeks apart. Stop globally, and switch to predominantly mixed mocks and targeted repair, when only a few named domains remain weak and your fresh-item accuracy has plateaued. Stopping is a response to measured stability, not to having exhausted a bank.
Which SCE Infectious Diseases resource should I use for my weakest component? Match the resource to the format of the weakness. For a knowledge gap in a clinical domain, a specialty bank aligned to the live CICE (such as Learn Infection) is the natural choice; for interpretation gaps, drill images, susceptibility tables and laboratory trends specifically; for guidance-sensitive gaps, go to the current dated source (NICE, CKS, UKHSA, BHIVA, BASHH, SmPC/eMC), not a revision summary. Use an unseen layer such as iatroX only to retest the repair on fresh wording, so you measure learning rather than recall.
Editorial notes and references
Written by Dr Kolawole Tytler, NHS GP and founder of iatroX. Last checked 21 July 2026. Vendor- and society-reported figures (question counts, prices, access terms) change without notice — verify them on each provider's page before relying on them. Medicines facts belong to the SmPC/eMC, and practice guidance to current NICE, CKS, SIGN, UKHSA and specialty-society sources; do not rely on any single revision product for currency. Disclosure: iatroX operates a UK question bank and competes with some resources named here; we have limited iatroX's role to unseen measurement and spaced retrieval, and have not claimed it is a specialty-depth CICE bank. Corrections are welcome via the feedback route on iatrox.com.
References: RCPath Infection examinations (FRCPath Part 1 in Infection / CICE) — rcpath.org; Federation of Royal Colleges of Physicians, SCE Infectious Diseases page confirming the 2017 final sitting — thefederation.uk; British Infection Association / Learn Infection — britishinfection.org and learn.britishinfection.org; completion is not coverage; the two-Q-bank rule; Your Q-Bank Percentage Is Not Your Exam Score; iatroX comparison hub — https://www.iatrox.com/compare.